de Vlas SJ - Search Results

1

Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.

Coffeng LE, Stolk WA, Hoerauf A, Habbema D, Bakker R, Hopkins AD, de Vlas SJ. Coffeng LE, et al. Among authors: de vlas sj. PLoS One. 2014 Dec 29;9(12):e115886. doi: 10.1371/journal.pone.0115886. eCollection 2014. PLoS One. 2014. PMID: 25545677 Free PMC article.

2

Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa.

Plaisier AP, Alley ES, Boatin BA, Van Oortmarssen GJ, Remme H, De Vlas SJ, Bonneux L, Habbema JD. Plaisier AP, et al. Among authors: de vlas sj. J Infect Dis. 1995 Jul;172(1):204-10. doi: 10.1093/infdis/172.1.204. J Infect Dis. 1995. PMID: 7797912 Clinical Trial.

3

Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling study.

Korenromp EL, Bakker R, De Vlas SJ, Robinson NJ, Hayes R, Habbema JD. Korenromp EL, et al. Among authors: de vlas sj. Sex Transm Dis. 2002 Apr;29(4):228-38. doi: 10.1097/00007435-200204000-00008. Sex Transm Dis. 2002. PMID: 11912465

4

HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial.

Korenromp EL, Bakker R, de Vlas SJ, Gray RH, Wawer MJ, Serwadda D, Sewankambo NK, Habbema JD. Korenromp EL, et al. Among authors: de vlas sj. AIDS. 2002 Nov 8;16(16):2209-18. doi: 10.1097/00002030-200211080-00014. AIDS. 2002. PMID: 12409743 Clinical Trial.

5

Validation of parasite transmission models: the example of onchocerciasis.

Nagelkerke NJ, de Vlas SJ, Alley ES. Nagelkerke NJ, et al. Among authors: de vlas sj. Neth J Med. 2002 Aug;60(7 Suppl):44-9; discussion 50-1. Neth J Med. 2002. PMID: 12430590

6

Assessing density dependence in the transmission of lymphatic filariasis: uptake and development of Wuchereria bancrofti microfilariae in the vector mosquitoes.

Stolk WA, Van Oortmarssen GJ, Subramanian S, Das PK, Borsboom GJ, Habbema JD, de Vlas SJ. Stolk WA, et al. Among authors: de vlas sj. Med Vet Entomol. 2004 Mar;18(1):57-60. doi: 10.1111/j.0269-283x.2004.0470.x. Med Vet Entomol. 2004. PMID: 15009446

7

Meta-analysis of age-prevalence patterns in lymphatic filariasis: no decline in microfilaraemia prevalence in older age groups as predicted by models with acquired immunity.

Stolk WA, Ramaiah KD, Van Oortmarssen GJ, Das PK, Habbema JD, De Vlas SJ. Stolk WA, et al. Among authors: de vlas sj. Parasitology. 2004 Nov;129(Pt 5):605-12. doi: 10.1017/s0031182004005980. Parasitology. 2004. PMID: 15552405

8

Anti-Wolbachia treatment for lymphatic filariasis.

Stolk WA, de Vlas SJ, Habbema JD. Stolk WA, et al. Among authors: de vlas sj. Lancet. 2005 Jun 18-24;365(9477):2067-8. doi: 10.1016/S0140-6736(05)66714-1. Lancet. 2005. PMID: 15964428 No abstract available.

9

Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.

Stolk WA, VAN Oortmarssen GJ, Pani SP, DE Vlas SJ, Subramanian S, DAS PK, Habbema JD. Stolk WA, et al. Among authors: de vlas sj. Am J Trop Med Hyg. 2005 Nov;73(5):881-7. Am J Trop Med Hyg. 2005. PMID: 16282298 Clinical Trial.

10

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling.

Stolk WA, de Vlas SJ, Habbema JD. Stolk WA, et al. Among authors: de vlas sj. Filaria J. 2006 Mar 28;5:5. doi: 10.1186/1475-2883-5-5. Filaria J. 2006. PMID: 16569234 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters